Covered recipient · General Payments record
HARRY R BURGER
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2023
$555.56
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $188.83 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $132.43 | 7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.53 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $17.60 | 1 |
| Acerta Pharma LLC | $16.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $25.96 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332513 | CMS |
| AbbVie Inc. | $8.01 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332515 | CMS |
| AbbVie Inc. | $29.04 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332517 | CMS |
| AbbVie Inc. | $25.18 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332519 | CMS |
| AbbVie Inc. | $17.85 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332521 | CMS |
| AbbVie Inc. | $20.57 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332523 | CMS |
| AbbVie Inc. | $5.82 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996332525 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.27 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014553553 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.53 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997015529 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $17.60 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034440997 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.